tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Similar Stocks

Compare
24 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$7.52
$149.22M
-5.09
-9.29%
2 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$4.34
$133.65M
-1.85
24.26%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.79
$157.25M
7.69
8.98%
5 Buy
1 Hold
0 Sell
Strong Buy
Nkarta
$1.88
$132.83M
-17.90%
4 Buy
1 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.47
$246.16M
-43.61%
4 Buy
1 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.78
$275.04M
-1.73
98.64%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
7.52
-1.17
-13.46%
AGEN
Agenus
3.79
0.96
33.92%
BDTX
Black Diamond Therapeutics
2.79
0.15
5.68%
NKTX
Nkarta
1.88
-0.43
-18.61%
CCCC
C4 Therapeutics
2.47
-1.84
-42.69%
KYTX
Kyverna Therapeutics, Inc.
8.78
4.54
107.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts